Background Sentinel lymph node biopsy (SLNB) has been the standard of care for clinically
node-negative women with invasive breast cancer (IBC); however, there is less agreement …

Backgrounds Sentinel lymph node biopsy (SLNB) is standard care as a staging procedure in
patients with invasive breast cancer. The axillary recurrence rate, even after positive SLNB …

BACKGROUND: Although sentinel lymph node biopsy (SLNB) has become the standard for
patients with clinically lymph node–negative breast cancer, less than one third of patients …

Breast cancer diagnosis and treatment have evolved dramatically over the past 4 decades.
Growing public education and awareness of breast cancer and advances in screening have …

543 Background: Sentinel lymph node biopsy (SLNB) has evolved as the standard of care
for early-stage breast cancer. The benefits of SLNB are accurate staging with minimal …

Breast cancer is the most commonly diagnosed cancer in Ontario for women, accounting for
almost 29% of all female incident cases (2). In Ontario, the guidelines for the surgical …

Background Sentinel lymph node biopsy (SLNB) has become a standard for axillary staging
for early breast cancer patients. Prior studies suggest that SLNB may be more sensitive for …

Background The widespread use of sentinel lymph node biopsy (SLNB) to replace axillary
dissection has broadened the indications for axillary staging in breast cancer. Recent …

Background: Recent data suggest sentinel lymph node biopsy (SLNBx) for invasive breast
cancer (IBC) is widely performed in the United States, often outside of a clinical trial. We …

Background The evidence on which to base guidelines for sentinel lymph node biopsy
(SLNB) in breast cancer is still limited. In order to facilitate the further implementation of …